Finance

The S&P 500 Is Still Standing but the Foundations Are Starting to Crack

Moderna (MRNA) Was Removed From the Nasdaq-100 and Is Going Back In. What Changed?

Retension Pharmaceuticals prices IPO at $12 per share on Nasdaq

Tokenization could unleash tens of billions of dollars in trapped capital, Nasdaq CEO says